Risultati per: Centri di riferimento HCV - CAMPANIA
Questo è quello che abbiamo trovato per te
I test salivari Hiv e Hcv a casa con Anlaids Lombardia
Parte in tutta Italia la campagna ‘A casa mi testo’
Rapporto Agenas, Bolzano in testa alla Rete Emergenza-Urgenza. Male la Campania
Per cardiologia tra migliori la Toscana e l’Emilia Romagna. Male il Sud e la Val d’Aosta. Bolzano, Emilia Romagna e Liguria in testa per l’assistenza ictus
Agenas,Bolzano in testa per Rete Emergenza-Urgenza,male Campania
Per cardiologia tra migliori Toscana, Er. Male Sud e Val d’Aosta
Schillaci, in Italia 194 centri di senologia. Il 30% degli ospedali entro gli standard per gli interventi
L’80% delle pazienti seguite da Breast Unit
Istituita la cabina di regia per la Rete Centri Pancreas Unit
Al ministero della Salute, coordinata da Sergio Alfieri
Salute, istituita cabina di regia per la Rete Centri Pancreas Unit
Comunicato del 20/03/2024 n°16
In Italia 183 centri di ricerca sui tumori, Sos per fondi e personale
Annuario Figoc, aumentati del 23%. Aiom, solo il 20% degli studi sulle nuove molecole è no profit
Kentucky Outreach Service Kiosk (KyOSK) Study protocol: a community-level, controlled quasi-experimental, type 1 hybrid effectiveness study to assess implementation, effectiveness and cost-effectiveness of a community-tailored harm reduction kiosk on HIV, HCV and overdose risk in rural Appalachia
Introduction
Many rural communities bear a disproportionate share of drug-related harms. Innovative harm reduction service models, such as vending machines or kiosks, can expand access to services that reduce drug-related harms. However, few kiosks operate in the USA, and their implementation, impact and cost-effectiveness have not been adequately evaluated in rural settings. This paper describes the Kentucky Outreach Service Kiosk (KyOSK) Study protocol to test the effectiveness, implementation outcomes and cost-effectiveness of a community-tailored, harm reduction kiosk in reducing HIV, hepatitis C and overdose risk in rural Appalachia.
Methods and analysis
KyOSK is a community-level, controlled quasi-experimental, non-randomised trial. KyOSK involves two cohorts of people who use drugs, one in an intervention county (n=425) and one in a control county (n=325). People who are 18 years or older, are community-dwelling residents in the target counties and have used drugs to get high in the past 6 months are eligible. The trial compares the effectiveness of a fixed-site, staffed syringe service programme (standard of care) with the standard of care supplemented with a kiosk. The kiosk will contain various harm reduction supplies accessible to participants upon valid code entry, allowing dispensing data to be linked to participant survey data. The kiosk will include a call-back feature that allows participants to select needed services and receive linkage-to-care services from a peer recovery coach. The cohorts complete follow-up surveys every 6 months for 36 months (three preceding kiosk implementation and four post-implementation). The study will test the effectiveness of the kiosk on reducing risk behaviours associated with overdose, HIV and hepatitis C, as well as implementation outcomes and cost-effectiveness.
Ethics and dissemination
The University of Kentucky Institutional Review Board approved the protocol. Results will be disseminated in academic conferences and peer-reviewed journals, online and print media, and community meetings.
Trial registration number
NCT05657106.
Fiagop, aumentare i centri di oncologia pediatrica
‘Rete nazionale e telemedicina per ridurre migrazione sanitaria’
Linee guida per i centri specializzati per la cura dell’epilessia
Association of HIV and HCV Infection With Carotid Artery Plaque Echomorphology in the MACS/WIHS Combined Cohort Study
Stroke, Ahead of Print. BACKGROUND:HIV and hepatitis C virus (HCV) are associated with increased risk of carotid artery atherosclerotic plaque and stroke. We examined associations of HIV- and HCV-related factors with echomorphologic features of carotid artery plaque.METHODS:This cross-sectional study included participants from the MACS (Multicenter AIDS Cohort Study)/WIHS (Women’s Interagency HIV Study) Combined Cohort Study who underwent high-resolution B-mode carotid artery ultrasound. Plaques were characterized from 6 areas of the right carotid artery. Poisson regression controlling for demographic and cardiometabolic risk factors determined adjusted prevalence ratios (aPRs) and 95% CIs for associations of HIV- and HCV-related factors with echomorphologic features.RESULTS:Of 2655 participants (65% women, median age 44 [interquartile range, 37–50] years), 1845 (70%) were living with HIV, 600 (23%) were living with HCV, and 425 (16%) had carotid plaque. There were 191 plaques identified in 129 (11%) women with HIV, 51 plaques in 32 (7%) women without HIV, 248 plaques in 171 (28%) men with HIV, and 139 plaques in 93 (29%) men without HIV. Adjusted analyses showed that people with HIV and current CD4+count
Fiagop, troppa disparità nei centri di oncologia pediatrica
Il 15 febbraio la Giornata mondiale contro il cancro dei bambini
In Campania solo metà degli over 65 vaccinata contro influenza
Dai dati Regione più vaccini ad anziani tra Salerno e provincia
De Luca, 'dati Agenas? Campania ultima per risorse'
‘Fare raffronti con altre regioni è atto di cialtroneria’
Nuovi centri urgenza in Emilia-Romagna, 'primi dati positivi'
Dopo Budrio apre il Cau di Vergato, saranno 30 entro fine anno